Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
24 /100
LOW RISK
Score updated Aug 28, 2026

AYTU — Aytu BioPharma, Inc. Dilution Risk Tracker

Track AYTU dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AYTU — Get alerts when the score changes →

As of August 28, 2026, Aytu BioPharma, Inc. (AYTU) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Aytu BioPharma, Inc. has a market capitalization of $24.58M, 10.73M shares outstanding, 38 institutional holders tracked. Stored dilution-related fields include 149.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AYTU.
🔔 Track AYTU — Get forecast alerts →

Market Data

Market Cap$24.58M
Shares Outstanding10.73M
Float7.61M
Cash$26.71M
Debt$10.48M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 9.9% shares (2026Q1 vs prior)
38 institutional holders · 4.21M shares
#1 Nantahala Capital Management, LLC 1.09M shares
#2 Stonepine Capital Management, LLC 792.3K shares
#3 AWM Investment Company, Inc. 619.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest326.2K
Days to Cover12.5
% of Float4.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2024-06-30
xbrl XBRL CONVERTIBLE 2021-06-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual AYTU Dilution Snapshot

Aytu BioPharma, Inc. (AYTU) has a DilutionScore of 24/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track AYTU Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AYTU — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AYTU
AYTU FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.